Vanguard Personalized Indexing Management LLC Has $350,000 Holdings in Doximity, Inc. (NASDAQ:DOCS)

Vanguard Personalized Indexing Management LLC raised its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 34.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,510 shares of the company’s stock after purchasing an additional 3,209 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Doximity were worth $350,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. LRI Investments LLC acquired a new stake in shares of Doximity in the 1st quarter valued at $27,000. Blue Trust Inc. increased its position in Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after buying an additional 1,193 shares during the last quarter. DekaBank Deutsche Girozentrale bought a new position in Doximity during the first quarter valued at about $46,000. First Horizon Advisors Inc. lifted its position in shares of Doximity by 80.0% in the second quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company’s stock worth $48,000 after buying an additional 760 shares during the last quarter. Finally, Van ECK Associates Corp boosted its stake in shares of Doximity by 19.7% during the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock worth $72,000 after acquiring an additional 427 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Doximity

In related news, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction that occurred on Monday, July 1st. The stock was sold at an average price of $28.00, for a total transaction of $70,000.00. Following the completion of the sale, the director now directly owns 10,258 shares of the company’s stock, valued at approximately $287,224. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CFO Anna Bryson sold 30,000 shares of the stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the completion of the transaction, the chief financial officer now directly owns 309,627 shares in the company, valued at approximately $10,836,945. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction that occurred on Monday, July 1st. The shares were sold at an average price of $28.00, for a total value of $70,000.00. Following the completion of the sale, the director now directly owns 10,258 shares of the company’s stock, valued at approximately $287,224. The disclosure for this sale can be found here. Insiders have sold a total of 37,951 shares of company stock valued at $1,271,018 over the last three months. 39.40% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Barclays lifted their price target on shares of Doximity from $31.00 to $35.00 and gave the company an “equal weight” rating in a research report on Friday, August 9th. Morgan Stanley lifted their target price on shares of Doximity from $25.00 to $26.00 and gave the stock an “underweight” rating in a report on Friday, August 9th. Truist Financial restated a “hold” rating and set a $35.00 price target (up from $31.00) on shares of Doximity in a report on Wednesday, August 14th. Needham & Company LLC raised Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research report on Friday, August 9th. Finally, Evercore ISI boosted their price objective on Doximity from $29.00 to $34.00 and gave the stock an “in-line” rating in a research report on Friday, August 9th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $32.42.

Doximity Trading Up 0.9 %

DOCS stock opened at $42.90 on Friday. Doximity, Inc. has a 1-year low of $19.89 and a 1-year high of $43.56. The business’s 50 day moving average is $34.82 and its 200-day moving average is $29.58. The firm has a market cap of $7.96 billion, a P/E ratio of 59.58, a P/E/G ratio of 5.80 and a beta of 1.27.

Doximity (NASDAQ:DOCS) last announced its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.06. The company had revenue of $126.68 million for the quarter, compared to analyst estimates of $119.88 million. Doximity had a net margin of 32.53% and a return on equity of 19.26%. Sell-side analysts forecast that Doximity, Inc. will post 0.8 EPS for the current year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.